CGON Stock: Price, Earnings History and SEC Filings
CG Oncology, Inc. (CGON) last traded at $64.68, up 1.91% on the latest session and down 8.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.90 against an analyst estimate of $-0.70, a miss of 28.6%.
$64.68 +1.91%
1 month-8.76%
52-week high$80.97
52-week low$35.80
Volume870,332
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CGON earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.90 | $-0.70 | -28.57% |
| Mar 2026 | May 8, 2026 | $-0.71 | $-0.58 | -22.41% |
| Dec 2025 | Feb 27, 2026 | $-0.51 | $-0.61 | +16.39% |
| Sep 2025 | Nov 14, 2025 | $-0.57 | $-0.57 | +0.00% |
CGON beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CGON
SEC filing data is not available right now. You can search for CGON on SEC EDGAR.
CGON news
No recent headlines found. The live terminal has the full news feed.
About CG Oncology, Inc.
CG Oncology, Inc. (CGON) is a US-listed public company on Nasdaq.